188 related articles for article (PubMed ID: 16900662)
21. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
Madeddu G; Spanu A; Solinas P; Babudieri S; Calia GM; Lovigu C; Mannazzu M; Nuvoli S; Piras B; Bagella P; Mura MS; Madeddu G
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of bone mineral density in Iranian HIV/AIDS patients.
Badie BM; Soori T; Kheirandish P; Izadyar S; SeyedAlinagh S; Foroughi M; Rostamian A; Mohraz M
Acta Med Iran; 2011; 49(7):460-7. PubMed ID: 21960080
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D and bone loss in HIV.
Hileman CO; Overton ET; McComsey GA
Curr Opin HIV AIDS; 2016 May; 11(3):277-84. PubMed ID: 26890209
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.
Mondy K; Yarasheski K; Powderly WG; Whyte M; Claxton S; DeMarco D; Hoffmann M; Tebas P
Clin Infect Dis; 2003 Feb; 36(4):482-90. PubMed ID: 12567307
[TBL] [Abstract][Full Text] [Related]
25. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
Krikke M; Klomberg RCW; van der Veer E; Tesselaar K; Verhaar HJJ; Hoepelman AIM; Arends JE
Neth J Med; 2017 May; 75(4):138-144. PubMed ID: 28522769
[TBL] [Abstract][Full Text] [Related]
26. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
Su YB; Xie J; Han Y; Qiu ZF; Li YL; Song XJ; Yu W; Li TS
Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1155-8. PubMed ID: 22883000
[TBL] [Abstract][Full Text] [Related]
27. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
Carr A; Miller J; Eisman JA; Cooper DA
AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
[TBL] [Abstract][Full Text] [Related]
28. Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies.
Walker Harris V; Brown TT
J Infect Dis; 2012 Jun; 205 Suppl 3(Suppl 3):S391-8. PubMed ID: 22577213
[TBL] [Abstract][Full Text] [Related]
29. [Bone mineral loss in patients with human immunodeficiency virus infection].
Olmos JM; González-Macías J
Enferm Infecc Microbiol Clin; 2008 Apr; 26(4):212-9. PubMed ID: 18381041
[TBL] [Abstract][Full Text] [Related]
30. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
Tsai MS; Hung CC; Liu WC; Chen KL; Chen MY; Hsieh SM; Sheng WH; Sun HY; Shih TT
J Microbiol Immunol Infect; 2014 Apr; 47(2):109-15. PubMed ID: 23073318
[TBL] [Abstract][Full Text] [Related]
31. Osteopenia in patients infected by the human immunodeficiency virus. A case control study.
Loiseau-Pérès S; Delaunay C; Poupon S; Lespessailles E; Ballouche N; Arsac P; Benhamou CL
Joint Bone Spine; 2002 Oct; 69(5):482-5. PubMed ID: 12477232
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients.
Cervero M; Torres R; Agud JL; Alcázar V; Jusdado JJ; García-Lacalle C; Moreno S
PLoS One; 2018; 13(4):e0196201. PubMed ID: 29709013
[TBL] [Abstract][Full Text] [Related]
33. Osteoporosis and HIV Infection.
Biver E
Calcif Tissue Int; 2022 May; 110(5):624-640. PubMed ID: 35098324
[TBL] [Abstract][Full Text] [Related]
34. Alcoholic liver disease and changes in bone mineral density.
López-Larramona G; Lucendo AJ; González-Delgado L
Rev Esp Enferm Dig; 2013; 105(10):609-21. PubMed ID: 24641458
[TBL] [Abstract][Full Text] [Related]
35. Bone mineral abnormalities in persons with HIV infection: signal or noise?
Singh K; Moyle GJ
AIDS Read; 2006 Aug; 16(8):407-10, 413-8. PubMed ID: 16933375
[TBL] [Abstract][Full Text] [Related]
36. [Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV].
Olczak A; Pawłowska M; Drózdz W
Przegl Epidemiol; 2008; 62(1):155-62. PubMed ID: 18536239
[TBL] [Abstract][Full Text] [Related]
37. Osteoporosis and fracture risk associated with HIV infection and treatment.
Compston J
Endocrinol Metab Clin North Am; 2014 Sep; 43(3):769-80. PubMed ID: 25169566
[TBL] [Abstract][Full Text] [Related]
38. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
[TBL] [Abstract][Full Text] [Related]
39. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
40. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.
Bruera D; Luna N; David DO; Bergoglio LM; Zamudio J
AIDS; 2003 Sep; 17(13):1917-23. PubMed ID: 12960824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
